{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:42:34Z","timestamp":1775904154213,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf03189675","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T00:09:19Z","timestamp":1280880559000},"page":"233-241","source":"Crossref","is-referenced-by-count":9,"title":["Disposition of a new rate-controlled formulation of prazosin in the treatment of hypertension during pregnancy: transplacental passage of prazosin"],"prefix":"10.1007","volume":"20","author":[{"given":"P.","family":"Bourget","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Edouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lesne-Hulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ribou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Baton-Saint-Mleux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lelaidier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03189675_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","volume":"2","author":"C.W.G. Redman","year":"1976","unstructured":"Redman C.W.G., Beilin L.J., Bonnar J., Ounsted M.K. (1976): Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet, 2, 753\u2013756.","journal-title":"Lancet"},{"key":"BF03189675_CR2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM198111263052205","volume":"305","author":"P.C. Rubin","year":"1981","unstructured":"Rubin P.C. (1981): Beta blockers in pregnancy. N. Engl. J. Med., 305, 1323\u20131326.","journal-title":"N. Engl. J. Med."},{"key":"BF03189675_CR3","first-page":"431","volume":"i","author":"P.C. Rubin","year":"1983","unstructured":"Rubin P.C., Butters L., Clark D., Low R., Reid J.L. (1983): Placebo controlled trial of atenolol in pregnancy associated hypertension. Lancet, i, 431\u2013434.","journal-title":"Lancet"},{"key":"BF03189675_CR4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2125.1981.tb01296.x","volume":"12","author":"K.J. Thorley","year":"1981","unstructured":"Thorley K.J., McAinsh J., Cruickshank J.M. (1981): Atenolol in the treatment of pregnancy-induced hypertension. Br. J. Clin. Pharmacol., 12, 725\u2013730.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03189675_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/bmj.1.6178.1591","volume":"1","author":"E.D.M. Gallery","year":"1979","unstructured":"Gallery E.D.M., Saunders D.M., Hunyor S.M., Gyory A.Z. (1979): Randomized comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. BMJ. 1, 1591\u20131594.","journal-title":"BMJ."},{"key":"BF03189675_CR6","first-page":"169","volume":"94","author":"W.F. Lubbe","year":"1981","unstructured":"Lubbe W.F., Hodge J.V. (1981): Combined and adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. NZ Med. J., 94, 169\u2013172.","journal-title":"NZ Med. J."},{"key":"BF03189675_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/00003088-199121040-00001","volume":"21","author":"C. Knott","year":"1991","unstructured":"Knott C. (1991): The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations. Clin. Pharmacokinet., 21, 233\u2013241.","journal-title":"Clin. Pharmacokinet."},{"key":"BF03189675_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1981.tb01234.x","volume":"12","author":"P.C. Rubin","year":"1981","unstructured":"Rubin P.C., Scott P.J.W., Reid J.L. (1981): Prazosin disposition in young and elderly subjects. Br. J. Clin. Pharmacol., 12, 401\u2013404.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03189675_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2125.1983.tb02213.x","volume":"16","author":"P.C. Rubin","year":"1983","unstructured":"Rubin P.C., Butters L., Low R.A., Reid J.L. (1983): Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension. Br. J. Clin. Pharmacol., 16, 543\u2013547.","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"suppl. 2A","key":"BF03189675_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0002-9343(89)90111-3","volume":"87","author":"J.T. DiPiro","year":"1989","unstructured":"DiPiro J.T. (1989): Controlling drug effects through improved oral formulations: the pharmacokinetics of Prazosin Gastrointestinal System. Am. J. Med., 87 (suppl. 2A), 31\u201335.","journal-title":"Am. J. Med."},{"key":"BF03189675_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0021-9673(00)90967-1","volume":"172","author":"Y.G. Yee","year":"1979","unstructured":"Yee Y.G., Rubin P.C., Meffin P. (1979): Prazosin determination by high pressure liquid chromatography using fluorescence detection. J. Chromatogr., 172, 313\u2013318.","journal-title":"J. Chromatogr."},{"key":"BF03189675_CR12","first-page":"17","volume-title":"Biopharmaceutics and Clinical Pharmacokinetics","author":"M. Gibaldi","year":"1984","unstructured":"Gibaldi M. (1984): Biopharmaceutics and Clinical Pharmacokinetics. 3 edn. Philadelphia, Lea & Fabiger, pp. 17\u201328.","edition":"3 edn."},{"key":"BF03189675_CR13","first-page":"1","volume":"48","author":"P. Bourget","year":"1993","unstructured":"Bourget P., Delouis J.M. (1993): Methods for assessment of area under the curve in pharmacokinetic analysis. Th\u00e9rapie, 48, 1\u20135.","journal-title":"Th\u00e9rapie"},{"key":"BF03189675_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/BF01062109","volume":"6","author":"K. Yamaoka","year":"1978","unstructured":"Yamaoka K., Nakagawa T., Uno T. (1978): Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm., 6, 547\u2013580.","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"BF03189675_CR15","unstructured":"Data on file, Pfizer Laboratories, New York."},{"key":"BF03189675_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jps.2600720734","volume":"72","author":"W.A. Colburn","year":"1983","unstructured":"Colburn W.A. (1983): Estimating the accumulation of drugs. J. Pharm. Sci., 72, 833\u2013834.","journal-title":"J. Pharm. Sci."},{"key":"BF03189675_CR17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/clpt.1988.77","volume":"43","author":"H.L. Elliott","year":"1988","unstructured":"Elliott H.L., Vincent J., Meredith P.A., Reid J.L. (1988): Relationship between plasma prazosin concentrations and \u03b1-antagonism in humans: comparison of conventional and rate-controlled (Oros) formulations. Clin. Pharmacol. Ther., 43, 582\u2013587.","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF03189675_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2125.1983.tb01556.x","volume":"15","author":"J. Vincent","year":"1983","unstructured":"Vincent J., Elliott H.L., Meredith P.A., Reid J.L. (1983): Doxazosin, an alpha1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Br. J. Clin. Pharmacol., 15, 719\u2013725.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03189675_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF01058953","volume":"11","author":"P.A. Meredith","year":"1983","unstructured":"Meredith P.A., Kelman A.W., Elliott H.L., Reid J.L. (1983): Pharmacokinetic and pharmacodynamic modeling of trimazosin and its major metabolite. J. Pharmacokinet. Biopharm., 11, 323\u2013335.","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"BF03189675_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0163-7258(80)90085-6","volume":"10","author":"B. Krauer","year":"1980","unstructured":"Krauer B., Krauer F., Hytten F.E. (1980): Drug disposition and pharmacokinetics in the maternal placenta fetal unit. Pharmacol. Ther. 10, 301\u2013342.","journal-title":"Pharmacol. Ther."},{"key":"BF03189675_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.5.4_Pt_2.II18","volume":"5","author":"K.D. Raemsch","year":"1983","unstructured":"Raemsch K.D., Sommer J. (1983): Pharmacokinetics and metabolism of nifedipine. Hypertension, 5, 18\u201324.","journal-title":"Hypertension"},{"issue":"suppl. 2A","key":"BF03189675_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0002-9343(89)90113-7","volume":"87","author":"W. Singleton","year":"1989","unstructured":"Singleton W., Dix R.K., Monsen L., et al. (1989): Efficacy and safety of Minipress XL, a new once-a-day formulation of prazosin. Am. J. Med., 87 (suppl. 2A), 45\u201352.","journal-title":"Am. J. Med."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03189675\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T23:33:24Z","timestamp":1652744004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03189675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF03189675"],"URL":"https:\/\/doi.org\/10.1007\/bf03189675","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}